Compound ID | 3542
Synonym(s): 8918
Class: PptT inhibitor
| Details of activity: | Active against Mycobacterium tuberculosis and Mycobacterium smegmatis; coenzyme A (CoA) metabolism inhibitor (inhibits phosphopantetheinyl transferase [PptT] involved in Mycobacterium tuberculosis lipid metabolism) |
| Propensity to select resistant mutants: | Yes, 10^-7 mutation frequency at 4x MIC |
| Description: | Synthetic compound; identified from screening the Sanofi collection of small molecules; shows no cytotoxicity towards human hepatoma cells; rapidly metabolised by microsomes; as effective as rifampicin in preventing Mycobacterium tuberculosis replication in mice lungs when administered orally |
| Institute where first reported: | Microbiotix, Inc. |
| Year first mentioned: | 2019 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|